Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ocugen Inc
(NQ:
OCGN
)
1.020
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen Inc
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
32
33
Next >
What's Next For Ocugen Stock As It Nears Key Resistance Level?
July 06, 2021
Ocugen Inc. (NASDAQ: OCGN) shares traded higher Tuesday after the company announced that its coronavirus vaccine co-development partner Bharat Biotech reported...
Via
Benzinga
Exposures
COVID-19
42 Stocks Moving In Tuesday's Mid-Day Session
July 06, 2021
Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47. BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday. Bridgeline...
Via
Benzinga
3 Reasons Ocugen Stock Should Maintain Its Upward Trajectory
July 06, 2021
OCGN stock has been counted out of the vaccine race many times, but there is plenty of room for optimism moving forward.
Via
InvestorPlace
OCGN Stock: The Big Covaxin News That Has Ocugen Rallying Today
July 06, 2021
OCGN stock is racing higher this morning following better-than-expected results from Ocugen's vaccine partner. Here is what you need to know.
Via
InvestorPlace
Exposures
COVID-19
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 06, 2021
Gainers Advaxis (NASDAQ:ADXS) stock rose 46.9% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $100.9 million. Axcella...
Via
Benzinga
Ocugen Preps US Filings For COVID-19 Vaccine As New Data Shows Overall Efficacy Of Around 79%
July 06, 2021
Armed with new data from its development partner Bharat Biotech, Ocugen Inc (NASDAQ: OCGN) plans to press ahead with plans to file for approval of their COVID-19...
Via
Benzinga
Exposures
COVID-19
28 Stocks Moving in Tuesday's Pre-Market Session
July 06, 2021
Gainers Odonate Therapeutics, Inc. (NASDAQ: ODT) shares rose 38.3% to $4.80 in pre-market trading following 13G from Ikarian Capital showing a 5.2% stake in the company. BSQUARE...
Via
Benzinga
Don’t Play the Ocugen Stock Short Squeeze Before You Read This Warning!
July 06, 2021
Growing trends involving OCGN stock suggest that the bears may have the upper hand this time.
Via
InvestorPlace
Exposures
COVID-19
Ocugen Has Had a Good Run, but the Math Says It’s Over
July 06, 2021
Ocugen was a penny stock is up 180% for the year. But all good things must come to an end. And it’s time to let go of OCGN stock.
Via
InvestorPlace
Exposures
COVID-19
3 Tips for Coronavirus Investing Right Now
July 05, 2021
Whether you're a cautious or aggressive investor, there's something for you in this space.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
One Bright Spot for Ocugen Investors
July 03, 2021
It may equal some coronavirus vaccine revenue ahead.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
12 Health Care Stocks Moving In Friday's After-Market Session
July 02, 2021
Gainers Odonate Therapeutics (NASDAQ:ODT)...
Via
Benzinga
Opportunity for Investors With Substantial Losses to Lead the Ocugen, Inc. Class Action Lawsuit - OCGN
July 02, 2021
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
How Risky Is Ocugen After Its Recent Setback?
July 02, 2021
The U.S. vaccine market has slipped farther out of reach.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Better Short-Squeeze Stock: Clover Health or Ocugen?
July 02, 2021
Both have the necessary ingredients for explosive short-squeeze returns.
Via
The Motley Fool
Why Ocugen Shares Are Slipping Today
July 01, 2021
It could be due to the aftereffects of being included in a major stock index.
Via
The Motley Fool
Sell Ocugen Stock Before the Other Shoe Finally Drops
June 30, 2021
The bad news with Covaxin hasn't sunk in yet with OCGN stock investors, so get out while the stock still remains elevated.
Via
InvestorPlace
Exposures
COVID-19
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
June 30, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
What's Going On With Ocugen (OCGN) Stock Today?
June 30, 2021
Ocugen Inc (NASDAQ: OCGN) shares are trading 1.6% higher in the pre-market session on Wednesday amid high social media interest. The company's shares had closed nearly 2%...
Via
Benzinga
ROSEN, A LEADING LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important August 17 Deadline in Securities Class Action – OCGN
June 29, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
NASDAQ:OCGN Shareholder Alert: Lawsuit Alleges Securities Laws Violations by Ocugen, Inc.
June 29, 2021
San Diego, CA -- (SBWIRE) -- 06/29/2021 -- An investor, who purchased NASDAQ:OCGN shares, filed a lawsuit against Ocugen, Inc. over alleged violations of Federal Securities Laws.
Via
SBWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
If Ocugen Stock Is Worth $8, I’ll Eat My Hat
June 29, 2021
OCGN stock at $8.35 looks ridiculously overvalued given the change in course
Via
InvestorPlace
Exposures
COVID-19
OCGN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ocugen, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
June 29, 2021
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Ocugen Stock Is A Bust After Covaxin’s Emergency Use Rejection
June 29, 2021
OCGN stock is of no value to investors now that federal regulators closed the door on its Covid-19 vaccine commercialization efforts.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
Is It Too Late to Buy Ocugen Stock?
June 29, 2021
The company has found a partner to manufacture its COVID-19 vaccine -- but will it be all for naught?
Via
The Motley Fool
Exposures
COVID-19
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
June 29, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Get Rid of Ocugen Stock While You Can as the Bad News Piles Up
June 29, 2021
After OCGN stock rallied due to factors that were not based on fundamentals, investors should sell the shares.
Via
InvestorPlace
Exposures
COVID-19
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
June 28, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ocugen, Inc. (OCGN)
June 25, 2021
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
June 25, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
< Previous
1
2
...
22
23
24
25
26
27
28
29
30
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.